Reynolds Capital Management’s United Therapeutics UTHR Stock Holding History

Reynolds Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,900	Closed	-$331K	–	195
2015 Q2	$331K	Sell	1,900 -1,100	-37%	-$198K	0.32%	115
2015 Q1	$517K	Buy	3,000 +500	+20%	+$76.2K	0.45%	63
2014 Q4	$324K	Buy	+2,500	New	+$322K	0.27%	146
2014 Q2	–	Sell	-2,300	Closed	-$216K	–	387
2014 Q1	$216K	Sell	2,300 -2,700	-54%	-$276K	0.14%	325
2013 Q4	$565K	Buy	5,000 +800	+19%	+$72.1K	0.32%	85
2013 Q3	$331K	Buy	+4,200	New	+$307K	0.21%	178

Other funds holding UTHR

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Reynolds Capital Management's UTHR Position: Q3 2015 in Review

Reynolds Capital Management sold out of United Therapeutics (UTHR) in Q3 2015, closing a stake of 1,900 shares — an estimated $331K sold.

Reynolds Capital Management first reported a position in UTHR in Q3 2013 and held it in 6 quarters. The position peaked at $565K in Q4 2013. 372 funds tracked by Wall St. Rank hold UTHR as of Q3 2015.

Reynolds Capital Management reported no remaining United Therapeutics position as of Q3 2015 after selling out during the quarter.
Reynolds Capital Management sold 1,900 United Therapeutics shares in Q3 2015, an estimated $331K.
Reynolds Capital Management first reported a position in United Therapeutics in Q3 2013 and held it in 6 quarters.
Reynolds Capital Management's United Therapeutics position peaked at $565K in Q4 2013.
372 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2015.

Based on Reynolds Capital Management's 13F filing for Q3 2015, filed 22 Oct 2015.